BEVERLY, Mass. — LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, today announced that it has entered into the beta stage of product development of its flagship pathogen detection system. The Company recently completed a $5.7M equity financing through a bought deal short-form prospectus offering that included a fully-subscribed […]
Making genomics and artificial intelligence (AI) technologies work together can spot the origin of a genetic mutation causing cancer or a particular condition so that the treatment can be provided on time. Predicting treatment responses in cancer patients by integrating genomics and artificial intelligence is going to become a reality. A major collaborative research project “Artificial Intelligence […]
IRVINE, Calif. — Zymo Research Corp. has announced the appointment of Joseph R. Ecker, Ph.D., to Zymo Research’s Scientific Advisory Board. Dr. Ecker serves as Professor of Plant Molecular and Cellular Biology Laboratory and Director of the Genomic Analysis Laboratory at the Salk Institute for Biological Studies located in La Jolla, CA. He is also an Investigator for the Howard […]
Mick Messman Brings Over 20 Years of Global Agricultural Sales, Marketing, Product Development and Operations Experience to GreenLight MEDFORD, Mass. — GreenLight Biosciences, Inc., a biotechnology company developing RNA-based products for agricultural and pharmaceutical applications, today announced that Mick Messman has joined the Company as Chief Commercial Officer. Mr. Messman has over 20 years of global agricultural sales, […]
Streamlines genome interpretation to improve the utility of genomic data Illumina, Inc. announces the release of open source, novel artificial intelligence (AI) software that can distinguish between potential disease-causing mutations, and the millions of benign genetic variants in individuals. The new AI software for genome interpretation has been publicly released through Illumina’s BaseSpace Sequence Hub and GitHub. […]
MENLO PARK, Calif.–Quantapore Inc. announced the appointment of Dr. Alex Dickinson and Robert Proulx to the Board of Directors. Both Directors bring a wealth of experience in the development and commercialization of new technologies and operating high-growth businesses. Alex and Bob join Dr. Martin Huber and Dr. Sascha Dennstedt, Quantapore’s co-founders as well as Feng […]
La Vista, NE – Streck, Inc. and Cromoion SRL, a distributor of human and veterinary diagnostic products in Argentina, have signed a three-year distribution agreement for Streck’s full portfolio of controls, cell stabilization and molecular products. Streck’s cell stabilization products include Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens for […]
Researchers to access list of novel targets for Alzheimer’s disease treatment SEATTLE–Sage Bionetworks announces the launch of the Agora platform (agora.ampadportal.org) an interactive, web-based tool that allows researchers to explore curated genomic analyses of Alzheimer’s Disease (AD), including a list of early candidate target nominations for AD. The analyses accessible through Agora represent the culmination of over […]
BASEL, Switzerland and WALTHAM, Mass. — Enzyvant, a biopharmaceutical company focused on developing innovative treatments for people living with rare diseases, today announced that it has formed a collaboration with PerkinElmer Genomics, a global genomic testing company. PerkinElmer Genomics will leverage its network of global labs and testing platform to offer eligible providers and patients around the world […]
AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications. The latest tool in genome science – CRISPR/Cas9 is a simple and efficient genome editing tool which allows for specific genome disruption and replacement resulting in high specificity and low cell toxicity. AMSBIO CRISPR Complete kits are […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
